10 Rta is a transcription factor encoded by BRLF1 of the Epstein-Barr virus (EBV). This factor is expressed during the immediate-early stage of the lytic cycle to activate the genes required for EBV lytic development. Although transcription activation by Rta is 15 frequently associated with the binding of Rta to the Rta-response element (RRE) in promoters, Rta sometimes activates promoters without an RRE. Here we show that Rta interacts with an Sp1-interacting protein, MBD1-containing chromatin-associated factor 1 20 (MCAF1). This interaction is critical to the formation of an Sp1-MCAF1-Rta complex at Sp1 sites. Therefore, following lytic induction and the expression of Rta, Rta increases Sp1-mediated transcription.
an RRE in their promoter (10-13). Although exactly how Rta activates these promoters is unclear, an earlier work demonstrated that the Sp1 sites in the BRLF1 promoter (Rp) are critical to the activation by Rta (10). However, Rta does not appear to interact directly with Sp1 to activate the 55 transcription (10).
MBD1-containing chromatin-associated factor 1 (MCAF1), a human homolog of murine ATFa-associated modulator, is a transcription factor of 1270 amino acids with a transcriptional repression activity (14) . MCAF1 enhances SETDB1/ESET-60 mediated histone H3 methylation (15) to promote the formation of heterochromatin domains (16) . MCAF1 also interacts with MBD1 and Sp1 (14) . The interaction between MCAF1 and MBD1 is crucial to MBD1-dependent transcriptional repression (14) ; when it binds to MBD1, MCAF1 forms a repressive complex with MBD1 to prevent transcription from a methylated promoter (14) . However, when binding to Sp1, MCAF1 becomes a coactivator to enhance Sp1-mediated transcription (14) . This work finds that Rta interacts with MCAF1, which facilitates the formation of an Sp1-MCAF1-Rta 70 complex on the Sp1-binding site to autoregulate the transcription of BRLF1 and regulate the host genes in EBV-infected cells. The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org cultured in DMEM supplemented with 10% FCS. P3HR1 cells were treated with 3 ng/ml of 12-O-tetradecanoylphobol-13-acetate (TPA) and 3 mM sodium butyrate to activate the EBV lytic cycle (17) . Maxi-EBV is a laboratory-constructed 5 EBV strain that contains an F replicon (18) .
MATERIALS AND METHODS

Cell lines and EBV lytic induction
Plasmids
Plasmid pCMV-R contains BRLF1 transcribed from the cytomegalovirus (CMV) immediate-early promoter. Plasmids pcDNA-MCAF1, pHA-Rta, pRRE, pRp-luc, pCMV-10 R(K213A) and pET-Rta were described elsewhere (17, 19) .
Plasmid pGEX-4T1, which expresses GST, was purchased from Amersham Pharmacia Biotech (Hong Kong). The DNA fragment that encodes p621 (amino acids 650-1270 of MCAF1) was isolated from pcDNA-MCAF1 (14) by 15 HpaI-XhoI digestion and inserted into the SmaI and XhoI sites to yield plasmid pGST-621. The Sp1 gene was amplified by PCR, using GST-Sp1 (5 0 -CCGGAATTCATGGATG-AAATGACAGCTGTG) and Sp1-His (5 0 -ACGCGTCGAC-AAGCCATTGCCACTGATA) as primers, and plasmid 20 pCMV-Sp1 (20) , which was obtained from Guntram Suske, as a template. The fragment was inserted into the EcoRV and SalI sites of pET32a or pGEX-4T1 to form plasmid pET-Sp1 or pGST-Sp1, respectively. Plasmid pR-Sp1 was constructed by inserting a double-stranded oligonucleotide that con-25 tained a sequence that covers the region between À53 and +4 of Rta, into the SmaI site of pGL2-Basic (Promega Corp., Madison, WI). In this sequence (5 0 -GTCCCGCCCATGCC-AGATATCCATAAAAGACCAGTAATCCATGTCAGCCG-GCCTTT), a ZRE sequence and a nucleotide residue that 30 precedes the sequence was mutated from 5 0 -ATGGCTCA to 5 0 -GATATCCA (Fig. 1) . The Sp1 site (5 0 -CCGCCC), the mutated ZRE sequence and the TATA sequence (5-AT-AAAA) are underlined. Plasmid pR-mSp1 includes the same sequence as pR-Sp1, except in that the Sp1 site, 5 0 -CCGCCC, 35 was changed to 5 0 -ATTAAT. R-TATA (5 0 -CATAAAAGAC-CAGTAATCCATGTCAGCCGGCCTTT), which contains a sequence from the region from À32 to +4 in Rp, was inserted into the SmaI site of pGL2-Basic to construct plasmid pTA. Plasmid pSp1-luc contains four of the six Sp1-binding sites 40 from the promoter of p21 upstream of the firefly luciferase gene (luc) in pTA. Plasmid pFlag-Rta that expresses fulllength Flag-tagged Rta was constructed by inserting a PCRamplified BRLF1 fragment into pCMV-Tag2A (Stratagene) at the EcoRI and XhoI sites. The same approach was employed to 45 produce deletions in Flag-tagged Rta (Flag-Stu, Flag-HincII, Flag-HinfI and Flag-EcoRII), which lacked the regions between amino acids 1 and 190, 1 and 254, 1 and 290, and 1 and 360, respectively. Plasmid pEGFP-MCAF1-N, which contains the N-terminal 561 amino acids of MCAF1, was 50 constructed by inserting a PCR-amplified fragment into the HindIII and SmaI sites of pEGFP-C1 (Clontech). Plasmids pEGFP-MCAF1-D1 and pEGFP-MCAF1-D2 were also constructed using the same strategy. An Rta deletion mutant, HA-RN290 that contains the N-terminal 290 amino acids of 55 Rta was constructed by inserting a PCR fragment into the EcoRI and XhoI sites of pcDNA3-HA. Plasmid pEGFP-R255/290, which encodes the region between amino acid 255 and 290 in Rta fused with green fluorescence protein (GFP), was constructed by inserting a PCR-amplified fragment 60 into the EcoRI and SalI sites of pEGFP-C1. Plasmid pp21-luc was obtained from W.-C. Hung. Plasmids pp16-luc and pSNRPN-luc have been described elsewhere (14) .
Yeast two-hybrid screen
The binding partners of Rta were identified by yeast two-
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hybrid screen with a bait plasmid, pR476, and a human testes cDNA library, following a method described elsewhere (17) .
GST-pull-down assay
GST or GST-p621 at a concentration of 40 ng/ml in 500 ml of NETN buffer (20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM 70 EDTA and 0.5% NP-40), containing 10 mg/ml each of leupeptin, aprotinin and 4-(2-aminoethyl)-benzenesulfonyl fluoride, was added to 30 ml of glutathione-Sepharose 4B beads (Amersham Pharmacia Biotech). The mixture was incubated with shaking for 1 h at 4 C. The beads were washed 75 three times in NETN buffer and added to a lysate (300 ml) prepared from Escherichia coli BL21(DE3)(pET-Rta) or E.coli BL21(DE3)(pET-Sp1). The reaction mixture was incubated on ice for 1 h. The beads were then washed in NETN buffer. An equal volume of 2· electrophoresis sample 80 buffer was added to the mixture and proteins were extracted from the beads by heating at 95 C for 5 min. Proteins were finally separated by SDS-PAGE (21) .
Immunoprecipitation
P3HR1 cells (1 · 10 7 ) treated with TPA and sodium butyrate 85 were washed in phosphate-buffered saline (PBS). Lysate was prepared using radioimmune precipitation assay (RIPA) buffer, following a method described elsewhere (17) . To the supernatant, anti-Rta (1:500 dilution) (Argene, Varilhes, France), anti-MCAF1 antibody (1:500 dilution) (14) or anti-
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Sp1 antibody (1:2000 dilution) (Santa Cruz Biotechnology Inc., Santa Cruze, CA) was added and incubated at 4 C for 1 h. Protein-A/G agarose beads (30 ml) (Oncogene, Boston, MA) were added to the lysate and the mixture was incubated with shaking for 1 h at 4 C. The beads were finally collected 95 by centrifugation and washed three times in RIPA buffer.
Proteins that bound to the beads were eluted by adding 20 ml of 2· electrophoresis sample buffer and analyzed by immunoblotting (IB) with anti-Rta, anti-MCAF1 or anti-Sp1 antibody.
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DNA-affinity precipitation assay (DAPA)
A 5 0 -biotin end-labeled double-stranded probe (Rp64/28) that contains a sequence from À64 to À28 in Rp (5 0 -ATAT-TGCGATTGTCCCGCCCATGCCAATGGCTCATAA), was synthesized by Mission Biotech, Inc. (Taipei, Taiwan). A mut-105 ant probe (mRp28/64), with the same sequence except in that the Sp1 site was changed from 5 0 -CCGCCC to 5 0 -ATTAAT, was used as a negative control. In both Rp64/28 and Rpm64/ 28, the ZRE in Rp was mutated from 5 0 -TGAGCCA to 5 0 -TGCAGTC (Fig. 1) . A biotin-labeled probe that contained 110 an RRE sequence (5 0 -CATGTCCCTCTATCATGGCG-CAGAC) from the BMLF1 promoter was utilized to demonstrate the binding of Rta to RRE. A cell lysate prepared from P3HR1 cells treated with TPA/sodium butyrate or 293T cells transfected with pCMV-R was mixed with 0.2 mg of a biotin-0.5 mM EDTA, 1 mM DTT and 10 mg/ml each of leupeptin, aprotinin and 4-(2-aminoethyl)-benzenesulfonyl fluoride. After it was incubated on ice for 45 min, DNA-protein com-5 plexes were then incubated with 30 ml of Streptavidin MagneSphere Paramagnetic particles (Promega Corp.), which were pre-equilibrated in the binding buffer with gentle shaking for 1 h at 4 C. DNA-protein complexes were then washed five times in the binding buffer. Next, 2· 10 electrophoresis sample buffer was added to the precipitated DNA-protein complex and the solution was boiled for 5 min to dissociate the complexes. Finally, the proteins were resolved by PAGE and detected by IB.
Chromatin immunoprecipitation (CHIP) assay 15 CHIP assay was performed according to a method described previously (19). P3HR1 cells (1 · 10 7 ) were transfected with pcDNA-MCAF1, pCMV-R and pR-Sp1 or pR-mSp1. Formaldehyde-fixed DNA-proteins complex was immunoprecipitated with anti-Rta, anti-Sp1 or anti-MCAF1 antibody. 20 The presence of Rp fragments in the precipitates was detected by PCR, using R-TATA1 (17) . Nuclei were visualized by staining with 5 mg/ml of 4 0 -6-diamidino-2-phenylindole (DAPI). Finally, cells were examined using an Olympus confocal laser-40 scanning microscope (Model Fluoview 500).
Transient transfection assay
Plasmids (10 mg) were transfected into P3HR1 or 293T cells by electroporation with a BioRad Gene-Pulser electroporator (Richmond, CA) (22) . Luciferase assay was performed, 45 using a luminometer (model LB593; Berthod, Bad Wildbad, Germany), according to a method described elsewhere (22) . Each transfection experiment was performed three times and each sample in each experiment was prepared in duplicate.
RESULTS
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Interaction among Sp1, p621 and Rta in yeast and in vitro A yeast two-hybrid screen was performed with pR476, which encodes the N-terminal 476 amino acids of Rta, to screen a human testes cDNA library constructed in pACT2. Of the 24 clones that produce a protein interacting with Rta, one 55 cDNA clone encoded p621 (23), which interacts with Sp1 and has a sequence identical to that in the C-terminal 621 amino acid region of a 1270 amino acid protein, MCAF1 (14) . The interaction between Rta and p621 was further verified by transforming the plasmid that expresses p621 into the 60 yeast strain Y190(pR476). A GST-pull-down assay was then performed with a bacterially expressed GST-p621 fusion protein. GST or GST-p621 bound to glutathione-Sepharose beads were added to the lysate that had been prepared from P3HR1 cells treated with TPA and sodium butyrate. 
Coimmunoprecipitation of Sp1, MCAF1 and Rta
293T cells were cotransfected with pCMV-R and pcDNA-MCAF1. A lysate was subsequently prepared and proteins Binding of the Sp1-MCAF1-Rta complex to the Sp1 site A double-stranded 37 bp biotin-labeled Sp1 probe, Rp64/28 (Figure 1) , which contains the sequence in the region between À64 and À28 of Rp, was added to a lysate prepared from 20 P3HR1 cells treated with TPA and sodium butyrate. Immunoblot analysis revealed that Sp1, MCAF1 and Rta were bound to the probe ( Figure 5 ), but these proteins did not bind to a mutant probe, Rpm64/28 ( Figure 5 ), whose sequence is identical to that of Rp64/28, except for a mutated 25 Sp1-binding sequence (Figure 1) .
Binding of the Sp1-MCAF1-Rta complex to the Sp1 sites in vivo CHIP analysis was performed to demonstrate the binding of Sp1, MCAF1 and Rta, to the Sp1 site on pR-Sp1 ( Figure 6 ). 30 Meanwhile, a parallel experiment was conducted with A biotin-labeled double-stranded Sp1 probe (Rp64/28) that contains the sequence from À64 and À28 of Rp was added to a lysate prepared from P3HR1 cells treated with TPA and sodium butyrate. A probe with an identical sequence, except for a mutated Sp1-binding sequence (Rpm64/28), was used as a negative control. Proteins bound to the probes were captured with streptavidin magnetic beads, extracted and detected by IB with anti-Sp1, anti-MCAF1 and anti-Rta antibodies.
pR-mSp1 whose sequence is identical to that of pR-Sp1, except in that the Sp1 sequence in Rp was mutated (Figure 1 ). P3HR1 cells were cotransfected with pcDNA-MCAF1, pCMV-R and pR-Sp1. After the cells were treated 5 with formaldehyde to cross-link DNA and proteins, DNA was isolated, sonicated and immunoprecipitated with anti-Sp1, anti-MCAF1 and anti-Rta antibody. PCR amplification of immunoprecipitated DNA with primers that are complementary to the vector sequences that flank the Rp segment 10 in pR-Sp1 demonstrated that these three antibodies immunoprecipitated the Rp segment ( Figure 6, lanes 3-5) . The DNA fragment was not amplified by PCR if anti-IgG antibody was utilized to immunoprecipitate DNA ( Figure 6 , lane 2). The Rp sequence was undetected when pR-mSp1 was cotrans-15 fected into the cells (Figure 6, lanes 7-10) . In this work, the ZRE sequence in Rp in both pR-Sp1 and pR-mSp1 was purposely mutated (Figure 1 ). Mutating this ZRE sequence was necessary to detect the binding of Sp1, MCAF1 and Rta to the Sp1 site by CHIP analysis, because according to 20 our unpublished results, MCAF1 and Rta interact with Zta and form a complex on ZRE.
Mapping the interaction domains in MCAF1 and Rta
Plasmids that expressed Rta and derivatives of MCAF1 fused to GFP ( Figure 7A ) were cotransfected into 293T cells. 25 Immunoblot analysis revealed that a GFP fusion protein, which contained the region between amino acids 562 and 981 of MCAF1 (GFP-MCAF1-D1), was coimmunoprecipitated with Rta by anti-Rta antibody ( Figure 7B, lane 7) . However, GFP alone ( Figure 7B , lane 5) and a GFP fusion protein 30 that contained the region from amino acid 1 to 561 ( Figure 7B 
Involvement of MCAF1 in Rta autoregulation
A reporter plasmid, pRp containing a full-length Rp, from À963 to +5 in BRLF1, was transfected into P3HR1 cells.
The reporter plasmid exhibited a background level of luciferase activity ( Figure 8A ). Meanwhile, cotransfecting 1 mg of pcDNA-MCAF1 had little effect on the transcription of luc from the reporter plasmid ( Figure 8A ). However, as expected, transfecting pCMV-R activated the transcription of 70 luc from the reporter plasmid ( Figure 8A ). Furthermore, transfecting pcDNA-MCAF1 enhanced the transcription of the luciferase gene activated by Rta in a dose-dependent manner ( Figure 8A ). The activity increased to $130, 180 and 300% of the original value when 1, 3 and 5 mg of pcDNA-MCAF1 were 75 cotransfected, respectively ( Figure 8A ). Similar results were obtained when another reporter plasmid, pR-Sp1, which contained the region between À53 and +8 in Rp (Figure 1 ), was transfected ( Figure 8B ). Luciferase activity exhibited by the reporter plasmid increased to $200% when pCMV-R and 80 5 mg of pcDNA-MCAF1 were cotransfected into the cells ( Figure 8B ). However, although transfecting pCMV-R activated an RRE-reporter plasmid, pRRE ( Figure 8C ), cotransfecting pcDNA-MCAF1 did not further increase the transcription activity in a dose-dependent manner ( Figure 8C ), indicating 85 that MCAF1 cannot increase the activity of Rta on RRE. Rta also activated an RRE promoter (pRRE) to a level of $1.5 times that of an Sp1 promoter (pR-Sp1) ( Figure 8D ), indicating that Rta activates an Sp1 promoter almost as efficiently as it does an RRE promoter.
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Activation of Rta expression and the EBV lytic cycle by MCAF1
To examine how MCAF1 influences the expression of Rta, 20 mg of pcDNA3.1 or pcDNA-MCAF1 was transfected into 5 · 10 6 of P3HR1 cells. Immunoblot analysis with anti-Rta 95 antibody did not detect the expression of Rta at 48 h after the transfection ( Figure 9A, lanes 2 and 3) . Cotransfecting the Rta expression was detected in the cells that were transfected with an empty vector ( Figure 9B, lanes 3 and 4) . However, the expression of Rta was markedly higher 1 and 2 days after the cells had been transfected with 20 mg of pcDNA-MCAF1 5 ( Figure 9B, lanes 5 and 6) . Meanwhile, the transfection also led to the expression of another EBV immediate-early protein, Zta ( Figure 9B , lanes 5 and 6). Meanwhile, pcDNA-MCAF1, pCMV-R and pRRE were also transfected into 293T cells. Transfecting pcDNA-MCAF1 did not increase 10 the capacity of pCMV-R to activate pRRE (data not shown), suggesting that MCAF1 did not activate the expression of Rta from the CMV promoter (data not shown). This finding shows that the increased Rta expression observed in this study is caused by the autoregulation of BRLF1 transcription 15 rather than the activation of the CMV promoter by MCAF1.
Activation of an RRE promoter by Rta is independent of MCAF1 and Sp1
Transfecting pcDNA-MCAF1 had little effect on the activation of an RRE-reporter plasmid by Rta, so we tested whether 20 the Rta-MCAF1-Sp1 complex could bind to RRE. A DAPA experiment with a biotin-labeled RRE probe showed that streptavidin beads could capture Rta ( Figure 10A, lane 2) . The beads did not capture Rta when a mutant probe (mRRE), in which the RRE sequence was mutated, was utilized ( Figure 10A, lane 3) , indicating that Rta binds to RRE. However, although Rta binds to MCAF1 (Figure 2 ), MCAF1 was not retained by the RRE probe ( Figure 10A, lane 2) . Additionally, by testing a panel of mutations in the DNA-binding 5 domain in Rta, we found that the K213 residue in Rta was critical to its binding to RRE; a lysine to alanine substitution of this residue (K213A) eliminated the binding capacity of Rta to RRE ( Figure 10A, lane 7) . This site was outside the MCAF1-binding domain, so this mutant protein could be used 10 to establish that activating an Sp1 promoter was independent of DNA binding. In a transient transfection study, both Rta and Rta(K213A) activated pR-Sp1 and pSp1-luc in 293T cells ( Figure 10B ). However, Rta(K213A) activated an RREreporter plasmid at a level $60% lower than that activated 15 by Rta ( Figure 10B ). Furthermore, cotransfecting pcDNA-MCAF1 did not affect the ability of HA, HA-R and Rta(K213A) to activate the pRRE promoter ( Figure 10B ).
Activation of Sp1-mediated transcription by Rta
We also tested whether Rta activates cellular promoters that 20 are activated by Sp1, including the promoters of p16, p21
and SNRPN, in an epithelial cell line, 293T. Transfecting pTA (Figure 11 ) alone, which contained a luciferase gene transcribed from a promoter with only a TATA sequence, expressed a low background value of luciferase activity. How-25 ever, the activity was activated 6.9-fold by cotransfection of pCMV-R. In parallel experiments, the p16 promoter was activated by pCMV-R 14.8-fold; the p21 promoter 8.2-fold and the SNRPN promoter 11.1-fold ( Figure 11 ).
DISCUSSION
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Rta is an EBV-encoded transcription factor, which is crucial in regulating the expression of EBV lytic gene. However, as well as regulating the EBV genes, Rta binds to Rb to release E2F1 Figure 10 . Transcriptional activation of Rp, an Sp1 promoter and an RRE promoter by Rta. (A) 293T cells were transfected with pCMV-R and the lysate was mixed with biotin-labeled probes, RRE and mRRE. Proteins bound to the probe were captured using streptavidin magnetic beads. Proteins extracted from the beads were analyzed by IB with anti-Rta and anti-MCAF1 antibody. A similar study was performed with 293T cells transfected with plasmids that expressed HA-Rta (HA-R) and Rta(K213A). (B) An empty vector (HA) and plasmids that expressed HA-Rta (HA-R) and Rta(K213A) (K213A) were cotransfected with reporter plasmids pR-Spl, pSp1-luc, pRRE and pGL2-Basic (closed rectangle). Meanwhile, pcDNA-MCAF1 was also cotransfected to examine whether MCAF1 influenced the transactivation activity of pRRE (open rectangle). The nonspecific activation of the transcription of the luciferase gene in pGL2-Basic by Rta and Rta(K213A) was probably attributed to a GGGAGG sequence, which resembles an Sp1-binding site, near the cloning site of the plasmid. Luciferase activity was determined at 24 h after transfection. Each transfection experiment was performed at least three times, and each sample in the experiments was prepared in duplicate. Figure 11 . Activating the promoters of p16, p21 and SNRPN by Rta. 293T cells were cotransfected with a reporter plasmid and pCMV-R (closed rectangle) or an empty vector (open rectangle). The reporter plasmids used herein contained a luciferase gene transcribed from the promoter of p16 (pp16), SNRPN (pSNRPN) and p21 (pp21). Plasmid pTA was a reporter plasmid that contained the TATA sequence of BRLF1. Activation of pTA by Rta was probably attributed to an Sp1-binding sequence, GGGAGG, in the multiple cloning site of the cloning vector, pGL2-Basic, that was used to construct pTA. Luciferase activity was determined at 24 h after transfection. Each transfection experiment was performed at least three times, and each sample in the experiment was prepared in duplicate.
from Rb to affect the cell cycle progression (24). Rta also modulates the phosphorylation of p38 and c-Jun-N-terminal kinases, ultimately affecting gene expression (11) , indicating that Rta affects not only the expression of EBV but also the 5 functions of cellular genes. Expression of Rta may be especially important to epithelial cells since Rta is constitutively expressed by EBV in these cells (25). Ragoczy et al. (10) established already that Rta activates the transcription of BRLF1 through two Sp1 sites in Rp. Sp1 is a crucial tran-10 scription factor that regulates many cellular genes, including those involved in housekeeping functions (26), cell differentiation (27), methylation (28) and oncogenesis (29). Hence, if Rta influences Sp1-mediated transcription, then the expression of Rta may profoundly affect the expression of cellular 15 genes. Accordingly, the ultimate goals of this work are to explore whether and how Rta affects the transcription of the genes that are activated by Sp1. A yeast two-hybrid screen was performed and revealed that an Sp1-binding protein, MCAF1, interacts with Rta. 20 The interaction was then verified in vitro with bacterially expressed proteins ( Figure 2 ) and in vivo by immunoprecipitation ( Figure 3) . Additionally, CHIP analysis revealed the formation of an Sp1-MCAF1-Rta complex on an Sp1 site in cells ( Figure 6 ). This work also verifies the results of Ragoczy 25 et al. (10), who noted that binding of Rta to Sp1 on an Sp1 probe could not be detected by electrophoretic mobility shift assay, perhaps because the protein complex is large. The putative protein-DNA complex might not enter the gel or might have dissociated during electrophoresis. We therefore used 30 DAPA to search for binding of the protein complex to a biotin-labeled Sp1 probe ( Figure 5 ). Additionally, a CHIP assay was performed to verify the binding of these proteins to the Sp1 site in Rp in vivo. This investigation was originally conducted in P3HR1 cells following EBV lytic induction. The 35 results indicated that MCAF1, Rta and Sp1 bind to Rp (data not shown). However, our subsequent investigations showed that MCAF1 and Rta also form a complex on ZRE (L.-K. Chang and S.-T. Liu, unpublished data). Only 7 nt separate the Sp1 site and ZRE in Rp, making it extremely 40 difficult to distinguish the binding of MCAF1 to the Sp1 site or ZRE by CHIP analysis. Therefore, CHIP assay was conducted by immunoprecipitating the proteins at the Sp1 site in Rp in pR-Sp1 (Figure 4) , in which the ZRE was mutated (Figure 1 ).
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We mapped the Rta-binding domain on MCAF1 in the region between amino acids 650 and 981 ( Figure 7B ). An earlier work revealed that the domains in MCAF1 that interact with Sp1 are located in D1 and D2 ( Figure 7A ) (14) . We determined that excess Rta does not affect the binding of 50 MCAF1 to Sp1 (Figure 2E ), indicating that although the Sp1-and Rta-binding regions overlap on MCAF1, Rta does not interfere with the binding of Sp1 to MCAF1. A lysine to alanine substitution on the K213 residue eliminated the capacity of Rta to bind to RRE ( Figure 10A ) and reduced 55 the capacity of Rta to activate an RRE-reporter plasmid ( Figure 10B ). The fact that K213 is located outside of the MCAF1-binding domain and the K213A mutation transactivates pR-Sp1 and pSp1-luc ( Figure 10B ) verifies that the transactivation of Rp by Rta is independent of RRE binding.
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Rta contains an RRE-binding domain located between amino acids 1 and 320 (Figure 7) , so the Rta-MCAF1-Sp1 complex might also bind to an RRE. However, our DAPA study indicates that this is not the case ( Figure 10A ). Additionally, transfecting pcDNA-MCAF1 has little effect on the activation of an RRE-reporter plasmid by Rta ( Figure 8C ), further indicating that MCAF1 does not participate in that activation. The lack of activation may be attributed to the fact that the RRE-binding domain and the MCAF1-binding domain overlap on Rta ( Figure 7) ; the binding of Rta to RRE 70 may prevent the binding of Rta to MCAF1.
We find that Rta activates Rp through Sp1, suggesting that the expression of Rta may also influence the transcription of the cellular genes that are regulated by Sp1. We chose three important regulating genes, p16, p21 and SNRPN, that contain 75 Sp1 sites to study the capacity of Rta to activate Sp1-mediated transcription. p16 is a tumor suppressor gene that contains aberrantly hypermethylated CpG islands in its promoter in cancer cells (30). p21 is known to regulate cell cycle progression (31); SNRPN is an imprinted gene, typically unmethy-80 lated and heavily methylated on the active paternal and inactive maternal alleles, respectively (32). pCMV-R activates the promoters of these three cellular genes 10-to 15-fold in transfection experiments ( Figure 11) . A reporter plasmid that contains four of the six Sp1 sites in the p21 promoter, Figure 9B, lanes 5 and 6) . Additionally, the transfection also led to the expression of Zta ( Figure 9A ), perhaps through the activation of BZLF1 transcription by Rta (11). These observations indicate that MCAF1 participates in EBV lytic activation in 293 cells. However,
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MCAF1 did not activate Rta expression in P3HR1 cells ( Figure 9A ). The expression of Rta was only evident when a little pCMV-R was cotransfected with pcDNA-MCAF1 ( Figure 9A, lanes 6 and 7) , suggesting that the expression of Rta is a prerequisite for EBV lytic activation by MCAF1. Moreover, an earlier work demonstrated that MCAF1 is abundant in the cell, which may explain why transfecting >10 mg of pcDNA-MCAF1 is required to detect the enhancement of the expression of EBV immediate-early genes ( Figure 9 ). This work demonstrates that Rta can activate gene transcription by two mechanisms, by which Rta activates not only 5 EBV but also cellular genes, which may ultimately affect cell cycle progression and oncogenesis. EBV in epithelial cells is generally known to express Rta constitutively (25). Therefore, activation of cellular genes and especially an EBV oncogene, BNLF1, may be crucial to the oncogenesis of the cells. How-10 ever, Rta expression causes the expression of Zta and activates the EBV lytic cycle (11) . Therefore, the cells die by the lytic production of EBV virions. Accordingly, the activation of host genes may only be possible if the lytic productive cycle is abortive. However, our work seems to indicate that 15 although Rta is constitutively expressed from maxi-EBV in 293 cells, the extent of Rta expression may not sufficiently activate the EBV lytic cycle. Not only was Rta expressed at a low level, but also the expression of Zta by the cells was undetected by immunoblot analysis ( Figure 9B , lane 2 The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome. Nature Genet., 36, 1099-1104.
